Endolysosomal Degradation Avoidance

Endolysosomal Degradation Avoidance is a strategic mechanism in intracellular delivery systems that enables therapeutic agents to circumvent degradation within the endolysosomal pathway by preventing or escaping fusion with lysosomes, thereby ensuring cargo bioavailability in the cytoplasm.

10

Publications

664

Citations

75

Authors

32

Institutions

Publications per year

2017–2026

7

Authors

75

  1. JB
    Juan B. Blanco‐Canosa

    Scripps Research Institute, United States

    1 publications · 128 citations

    1

    h-index

  2. TY
    Teerapong Yata

    Chulalongkorn University, Thailand

    1 publications · 44 citations

    1

    h-index

  3. EG
    Emmanuel Garcion

    Inserm, France

    1 publications · 143 citations

    1

    h-index

  4. UR
    Uta Reibetanz

    Leipzig University, Germany

    1 publications · 15 citations

    1

    h-index

  5. SW
    Sajee Waramit

    Imperial College London, United Kingdom

    1 publications · 44 citations

    1

    h-index

1–5 of 75

Venues

  1. Biomaterials

    2 publications · 163 citations

    2

    h-index

  2. ACS Applied Materials & Interfaces

    1 publications · 65 citations

    1

    h-index

  3. Journal of the American Chemical Society

    JACS · 1 publications · 127 citations

    1

    h-index

  4. Proceedings of the National Academy of Sciences

    PNAS · 1 publications · 44 citations

    1

    h-index

  5. Journal of Materials Chemistry B

    1 publications · 15 citations

    1

    h-index

1–5